KR102433868B1 - 연성 항콜린성 유사체를 위한 제제 - Google Patents

연성 항콜린성 유사체를 위한 제제 Download PDF

Info

Publication number
KR102433868B1
KR102433868B1 KR1020167028122A KR20167028122A KR102433868B1 KR 102433868 B1 KR102433868 B1 KR 102433868B1 KR 1020167028122 A KR1020167028122 A KR 1020167028122A KR 20167028122 A KR20167028122 A KR 20167028122A KR 102433868 B1 KR102433868 B1 KR 102433868B1
Authority
KR
South Korea
Prior art keywords
composition
topical composition
compound
subject
hyperhidrosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167028122A
Other languages
English (en)
Korean (ko)
Other versions
KR20160133492A (ko
Inventor
니콜라스 에스. 보도르
존 제이. 코렝
데이비드 앙굴로
Original Assignee
보도르 라보래토리즈, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 보도르 라보래토리즈, 인크. filed Critical 보도르 라보래토리즈, 인크.
Priority to KR1020227028128A priority Critical patent/KR102586868B1/ko
Publication of KR20160133492A publication Critical patent/KR20160133492A/ko
Application granted granted Critical
Publication of KR102433868B1 publication Critical patent/KR102433868B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
KR1020167028122A 2014-03-13 2015-03-12 연성 항콜린성 유사체를 위한 제제 Active KR102433868B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020227028128A KR102586868B1 (ko) 2014-03-13 2015-03-12 연성 항콜린성 유사체를 위한 제제

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201461952505P 2014-03-13 2014-03-13
US61/952,505 2014-03-13
US14/285,488 2014-05-22
US14/285,488 US20150259283A1 (en) 2014-03-13 2014-05-22 Formulation for soft anticholinergic analogs
PCT/US2015/020253 WO2015138776A1 (en) 2014-03-13 2015-03-12 Formulation for soft anticholinergic analogs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020227028128A Division KR102586868B1 (ko) 2014-03-13 2015-03-12 연성 항콜린성 유사체를 위한 제제

Publications (2)

Publication Number Publication Date
KR20160133492A KR20160133492A (ko) 2016-11-22
KR102433868B1 true KR102433868B1 (ko) 2022-08-19

Family

ID=54068191

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020167028122A Active KR102433868B1 (ko) 2014-03-13 2015-03-12 연성 항콜린성 유사체를 위한 제제
KR1020237033837A Pending KR20230145522A (ko) 2014-03-13 2015-03-12 연성 항콜린성 유사체를 위한 제제
KR1020227028128A Active KR102586868B1 (ko) 2014-03-13 2015-03-12 연성 항콜린성 유사체를 위한 제제

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020237033837A Pending KR20230145522A (ko) 2014-03-13 2015-03-12 연성 항콜린성 유사체를 위한 제제
KR1020227028128A Active KR102586868B1 (ko) 2014-03-13 2015-03-12 연성 항콜린성 유사체를 위한 제제

Country Status (20)

Country Link
US (8) US20150259283A1 (cg-RX-API-DMAC7.html)
EP (1) EP3116498B1 (cg-RX-API-DMAC7.html)
JP (5) JP6293919B2 (cg-RX-API-DMAC7.html)
KR (3) KR102433868B1 (cg-RX-API-DMAC7.html)
CN (3) CN110420167B (cg-RX-API-DMAC7.html)
AU (2) AU2015229243B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016021011B1 (cg-RX-API-DMAC7.html)
CA (1) CA2941649C (cg-RX-API-DMAC7.html)
DK (2) DK3116498T3 (cg-RX-API-DMAC7.html)
ES (1) ES2710292T3 (cg-RX-API-DMAC7.html)
HU (1) HUE041868T2 (cg-RX-API-DMAC7.html)
IL (1) IL247571B (cg-RX-API-DMAC7.html)
MX (1) MX369129B (cg-RX-API-DMAC7.html)
MY (1) MY183531A (cg-RX-API-DMAC7.html)
PH (1) PH12016501732A1 (cg-RX-API-DMAC7.html)
PL (1) PL3116498T3 (cg-RX-API-DMAC7.html)
PT (2) PT3116498T (cg-RX-API-DMAC7.html)
SG (1) SG11201607480SA (cg-RX-API-DMAC7.html)
WO (1) WO2015138776A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201607071B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9180081B2 (en) * 2005-03-03 2015-11-10 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
US11813284B2 (en) 2013-08-08 2023-11-14 Novan, Inc. Topical compositions and methods of using the same
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
CA3232529A1 (en) 2015-07-21 2017-01-26 Bodor Laboratories, Inc. Formulation for soft anticholinergic analogs
TWI767507B (zh) * 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
US11381304B2 (en) * 2017-08-30 2022-07-05 Iridium Satellite Llc Satellite communications with multiple classes of terrestrial terminal devices
CN114008023B (zh) * 2019-05-23 2024-02-09 科研制药株式会社 索吡溴铵的晶型及其制备方法
SG10201912063PA (en) * 2019-12-12 2021-07-29 Nat Skin Centre Singapore Pte Ltd A pharmaceutical formulation
JPWO2021177256A1 (cg-RX-API-DMAC7.html) 2020-03-03 2021-09-10
KR20220149551A (ko) 2020-03-03 2022-11-08 가켄 세이야쿠 가부시키가이샤 원발성 겨드랑이 다한증의 치료방법 및 그의 의약
KR102655121B1 (ko) 2021-09-17 2024-04-08 한국식품연구원 락토바실러스 사케이 k040706 균주 검출용 프라이머 세트 및 이의 용도
US11807604B1 (en) * 2022-02-16 2023-11-07 Miralogx Llc Pharmaceutical compounds, pharmaceutical compositions, and methods of treating asthma and other disorders
WO2024026412A1 (en) * 2022-07-28 2024-02-01 Tff Pharmaceuticals, Inc. Thin film freezing methods and compositions formulated from dispersed active agents
KR102611847B1 (ko) * 2023-03-27 2023-12-12 주식회사 이플라스크 무스카린 수용체 길항 활성을 갖는 신규한 피롤리디늄 화합물 및 이의 용도

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001523700A (ja) * 1997-11-20 2001-11-27 コルゲート・パーモリブ・カンパニー ジベンジリデンソルビトールを有する発汗抑制剤
US20090263341A1 (en) * 2005-11-10 2009-10-22 Bodor Nicholas S Soft anticholinergic esters

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK149832C (da) * 1981-07-17 1987-05-18 Riemann Claus Antiperspirantpraeparat bestaaende af to komponenter
DK483587D0 (da) * 1987-09-15 1987-09-15 Riemann & Co Aps Claus Antiperspirant praeparat
CA2014633C (en) * 1989-06-02 2000-07-18 Andrew D. Mccrea Stable anhydrous compositions for topical delivery of active materials
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
US5232689A (en) * 1990-12-21 1993-08-03 Dow Corning Corporation Translucent antiperspirant compositions
US5143719A (en) 1991-04-16 1992-09-01 Chesebrough-Pond's Usa Co. Anticalculus oral composition containing combinations of organophosphorus polycarboxylate cotelomers and inorganic polyphosphate salts
GB2280111B (en) 1993-07-16 1997-05-07 Union Camp Corp Clear gel antiperpirant compositions
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
US6319491B1 (en) 2000-04-11 2001-11-20 Michael B. Whipple Anti-sweat lotion
CA2461696A1 (en) * 2001-09-26 2003-04-03 Alison B. Lukacsko Compositions and methods for inhibiting eccrine perspiration in humans
JP2003113392A (ja) 2001-10-04 2003-04-18 Kiyomitsu Kawasaki 芳香・消臭組成物および該芳香・消臭組成物を含有する人体用芳香・消臭剤
US8252316B2 (en) * 2002-05-03 2012-08-28 Purepharm Inc. Method of topically applying glycopyrrolate solution using absorbent pad to reduce sweating
BR0308051A (pt) 2003-12-15 2005-09-06 Natura Cosmeticos Sa Composição base para preparação de formulações multifuncionais para o cuidado e proteção da pele e cabelo
US20060088496A1 (en) * 2004-10-25 2006-04-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide
US7087560B2 (en) * 2004-10-25 2006-08-08 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols
GB0428416D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
GB0428418D0 (en) * 2004-12-24 2005-02-02 Novartis Ag Organic compounds
BRPI0519481A2 (pt) * 2004-12-27 2009-02-03 Beiersdorf Ag glicopirrolato em preparaÇÕes cosmÉticas
WO2007046102A2 (en) * 2005-10-19 2007-04-26 Menni Menashe Zinger Methods for the treatment of hyperhidrosis
EP1957451B1 (en) 2005-11-10 2011-10-19 Nicholas S. Bodor Soft anticholinergic zwitterions
AU2006201878A1 (en) * 2006-03-13 2007-09-27 Foamix Ltd Foamable composition for hyperhidrosis
JP5371235B2 (ja) * 2006-12-06 2013-12-18 ロート製薬株式会社 皮膚外用剤
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
ES2969237T3 (es) 2007-10-18 2024-05-17 Rose U Llc Formulaciones tópicas de glicopirrolato y una toallita que contiene las mismas
US20100137357A1 (en) * 2008-11-26 2010-06-03 Koleng John J Compositions and methods for hyperhidrosis
US20140037713A1 (en) * 2012-08-03 2014-02-06 Antares Pharma Ipl, Ag Transdermal compositions for anti-cholinergic agents
CN105050596A (zh) 2013-03-15 2015-11-11 博多尔实验仪器公司 用于治疗多汗症的抗胆碱能格隆溴铵酯
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
WO2015138700A1 (en) 2014-03-13 2015-09-17 Bodor Laboratories, Inc. Use of selected anticholinergic zwitterions
CA3232529A1 (en) 2015-07-21 2017-01-26 Bodor Laboratories, Inc. Formulation for soft anticholinergic analogs
TWI767507B (zh) 2016-07-21 2022-06-11 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001523700A (ja) * 1997-11-20 2001-11-27 コルゲート・パーモリブ・カンパニー ジベンジリデンソルビトールを有する発汗抑制剤
US20090263341A1 (en) * 2005-11-10 2009-10-22 Bodor Nicholas S Soft anticholinergic esters

Also Published As

Publication number Publication date
US11034652B2 (en) 2021-06-15
PH12016501732B1 (en) 2017-02-06
US11084788B2 (en) 2021-08-10
EP3116498B1 (en) 2018-12-12
PT3116498T (pt) 2019-02-11
CN106456603B (zh) 2020-01-10
MX369129B (es) 2019-10-30
AU2015229243B2 (en) 2019-11-21
DK3325487T3 (da) 2021-08-02
JP2018115203A (ja) 2018-07-26
CN110917124A (zh) 2020-03-27
JP6461267B2 (ja) 2019-01-30
JP2019189650A (ja) 2019-10-31
IL247571B (en) 2020-03-31
MX2016011529A (es) 2016-12-07
IL247571A0 (en) 2016-11-30
EP3116498A1 (en) 2017-01-18
ES2710292T3 (es) 2019-04-24
KR20220119517A (ko) 2022-08-29
US12398102B2 (en) 2025-08-26
DK3116498T3 (en) 2019-03-11
AU2019257421A1 (en) 2019-11-21
BR112016021011A8 (pt) 2021-07-20
BR112016021011B1 (pt) 2022-12-13
JP2017507970A (ja) 2017-03-23
US20210198195A1 (en) 2021-07-01
US10947192B2 (en) 2021-03-16
KR102586868B1 (ko) 2023-10-11
HUE041868T2 (hu) 2019-05-28
US20200093791A1 (en) 2020-03-26
AU2015229243A1 (en) 2016-10-20
WO2015138776A1 (en) 2015-09-17
JP6762047B2 (ja) 2020-09-30
EP3116498A4 (en) 2017-11-08
SG11201607480SA (en) 2016-10-28
AU2019257421B2 (en) 2021-10-21
CN110917124B (zh) 2023-06-20
US10961191B2 (en) 2021-03-30
PH12016501732A1 (en) 2017-02-06
US20170020845A1 (en) 2017-01-26
KR20230145522A (ko) 2023-10-17
US20200113869A1 (en) 2020-04-16
JP6756763B2 (ja) 2020-09-16
ZA201607071B (en) 2018-12-19
US20210087142A1 (en) 2021-03-25
US20150320722A1 (en) 2015-11-12
CN110420167A (zh) 2019-11-08
KR20160133492A (ko) 2016-11-22
CA2941649C (en) 2021-03-02
CN106456603A (zh) 2017-02-22
BR112016021011A2 (pt) 2017-08-15
MY183531A (en) 2021-02-25
JP6293919B2 (ja) 2018-03-14
CA2941649A1 (en) 2015-09-17
JP2020079321A (ja) 2020-05-28
PT3325487T (pt) 2021-07-29
CN110420167B (zh) 2023-02-17
JP2017214429A (ja) 2017-12-07
US20150259283A1 (en) 2015-09-17
PL3116498T3 (pl) 2019-05-31
US20210078946A1 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
KR102433868B1 (ko) 연성 항콜린성 유사체를 위한 제제
JP6647692B2 (ja) ソフト抗コリン類似体のための製剤
HK40026881A (en) Formulation for soft anticholinergic analogs
HK40026881B (en) Formulation for soft anticholinergic analogs
HK40016903A (zh) 软性抗胆碱能药类似物的制剂
HK40016903B (en) Formulation for soft anticholinergic analogs
HK1233922A1 (en) Formulation for soft anticholinergic analogs
HK1233922B (zh) 软性抗胆碱能药类似物的制剂
HK1233505B (en) Formulation for soft anticholinergic analogs
HK1233505A1 (en) Formulation for soft anticholinergic analogs

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20161010

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
AMND Amendment
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200309

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20210910

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20220221

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20210910

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
PX0901 Re-examination

Patent event code: PX09011S01I

Patent event date: 20220221

Comment text: Decision to Refuse Application

Patent event code: PX09012R01I

Patent event date: 20211210

Comment text: Amendment to Specification, etc.

Patent event code: PX09012R01I

Patent event date: 20200309

Comment text: Amendment to Specification, etc.

PX0701 Decision of registration after re-examination

Patent event date: 20220512

Comment text: Decision to Grant Registration

Patent event code: PX07013S01D

Patent event date: 20220422

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20220221

Comment text: Decision to Refuse Application

Patent event code: PX07011S01I

Patent event date: 20211210

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

Patent event date: 20200309

Comment text: Amendment to Specification, etc.

Patent event code: PX07012R01I

X701 Decision to grant (after re-examination)
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20220812

PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20220812

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20220816

End annual number: 3

Start annual number: 1

PG1601 Publication of registration